2094 related articles for article (PubMed ID: 7794272)
1. Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials.
Hamby CV; Mendola CE; Potla L; Stafford G; Backer JM
Biochem Biophys Res Commun; 1995 Jun; 211(2):579-85. PubMed ID: 7794272
[TBL] [Abstract][Full Text] [Related]
2. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
[TBL] [Abstract][Full Text] [Related]
3. Expression of the tumor metastatic suppressor gene in mouse melanoma model: inverse association to metastatic potential.
Meng L
J Tongji Med Univ; 1998; 18(1):28-32, 36. PubMed ID: 10806798
[TBL] [Abstract][Full Text] [Related]
4. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential.
MacDonald NJ; De la Rosa A; Benedict MA; Freije JM; Krutsch H; Steeg PS
J Biol Chem; 1993 Dec; 268(34):25780-9. PubMed ID: 8245015
[TBL] [Abstract][Full Text] [Related]
5. A low NM23.H1 gene expression identifying high malignancy human melanomas.
Caligo MA; Grammatico P; Cipollini G; Varesco L; Del Porto G; Bevilacqua G
Melanoma Res; 1994 Jun; 4(3):179-84. PubMed ID: 7919963
[TBL] [Abstract][Full Text] [Related]
6. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
7. High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.
Zou M; Shi Y; al-Sedairy S; Farid NR
Br J Cancer; 1993 Aug; 68(2):385-8. PubMed ID: 8394105
[TBL] [Abstract][Full Text] [Related]
8. Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones.
van Golen KL; Risin S; Staroselsky A; Berger D; Tainsky MA; Pathak S; Price JE
Clin Exp Metastasis; 1996 Mar; 14(2):95-106. PubMed ID: 8605733
[TBL] [Abstract][Full Text] [Related]
9. A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction.
Chang CL; Strahler JR; Thoraval DH; Qian MG; Hinderer R; Hanash SM
Oncogene; 1996 Feb; 12(3):659-67. PubMed ID: 8637723
[TBL] [Abstract][Full Text] [Related]
10. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
[TBL] [Abstract][Full Text] [Related]
11. Localization of a second NM23 gene, NME2, to chromosome 17q21-q22.
Kelsell DP; Black DM; Solomon E; Spurr NK
Genomics; 1993 Aug; 17(2):522-4. PubMed ID: 8406509
[TBL] [Abstract][Full Text] [Related]
12. Expression of the nm23-2/NDP kinase alpha gene in rat mammary and oral carcinoma cells of varying metastatic potential.
Henderson BR
Br J Cancer; 1993 Nov; 68(5):874-8. PubMed ID: 8217603
[TBL] [Abstract][Full Text] [Related]
13. Expression of the nm23 metastasis-suppressor gene product in skin tumors.
Kanitakis J; Euvrard S; Bourchany D; Faure M; Claudy A
J Cutan Pathol; 1997 Mar; 24(3):151-6. PubMed ID: 9085150
[TBL] [Abstract][Full Text] [Related]
14. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.
Leone A; Flatow U; King CR; Sandeen MA; Margulies IM; Liotta LA; Steeg PS
Cell; 1991 Apr; 65(1):25-35. PubMed ID: 2013093
[TBL] [Abstract][Full Text] [Related]
15. mRNA levels of nm23 in murine ascites hepatoma (H22) clones with different lymphatic metastatic potential.
Jiang XP; Tang ZY; Liu KD; Zhou XD; Lin ZY; Ling MY; Wu XF
J Cancer Res Clin Oncol; 1996; 122(1):55-8. PubMed ID: 8543593
[TBL] [Abstract][Full Text] [Related]
16. Differential nm23 gene expression at the fetal-maternal interface.
Shi Y; Parhar RS; Zou M; al-Sedairy S; Farid NR
Br J Cancer; 1994 Sep; 70(3):440-4. PubMed ID: 8080727
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
[TBL] [Abstract][Full Text] [Related]
18. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells.
MacDonald NJ; Freije JM; Stracke ML; Manrow RE; Steeg PS
J Biol Chem; 1996 Oct; 271(41):25107-16. PubMed ID: 8810265
[TBL] [Abstract][Full Text] [Related]
19. Expression of NM23 in human melanoma progression and metastasis.
Easty DJ; Maung K; Lascu I; Véron M; Fallowfield ME; Hart IR; Bennett DC
Br J Cancer; 1996 Jul; 74(1):109-14. PubMed ID: 8679442
[TBL] [Abstract][Full Text] [Related]
20. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
